Logo image of CDXS

CODEXIS INC (CDXS) Stock Analyst Ratings

NASDAQ:CDXS - Nasdaq - US1920051067 - Common Stock - Currency: USD

2.82  +0.09 (+3.3%)

After market: 2.81 -0.01 (-0.35%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CDXS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.43. This target is 163.53% above the current price.
CDXS was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CDXS.
In the previous month the buy percentage consensus was at a similar level.
CDXS was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
CDXS Historical Analyst RatingsCDXS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -99 -90 -81 -72 -63 -54 -45 -36 -27 -18 -9 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.824.047.147.4311.55 - 43.26% 153.19% 163.53% 309.57%
CDXS Current Analyst RatingCDXS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2024-11-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-11-15 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-11-04 Benchmark Reiterate Hold
2024-09-20 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-29 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-08-19 Benchmark Downgrade Buy -> Hold
2024-08-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-05-30 Cantor Fitzgerald Initiate Overweight
2024-05-03 Benchmark Reiterate Buy -> Buy
2024-02-29 Benchmark Upgrade Hold -> Buy
2023-11-07 Benchmark Downgrade Buy -> Hold
2023-11-06 Piper Sandler Maintains Overweight -> Overweight
2023-09-01 Benchmark Reiterate Buy -> Buy
2023-08-14 Stifel Maintains Buy -> Buy
2023-07-21 Stephens & Co. Reiterate Overweight -> Overweight
2023-05-09 Benchmark Maintains Buy
2023-05-09 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-04-17 Piper Sandler Maintains Overweight
2023-02-27 HC Wainwright & Co. Maintains Buy
2023-01-19 Piper Sandler Maintains Overweight
2022-11-07 HC Wainwright & Co. Maintains Buy
2022-08-08 HC Wainwright & Co. Maintains Buy
2022-07-18 HC Wainwright & Co. Maintains Buy
2022-07-15 Cowen & Co. Maintains Outperform
2022-07-15 Piper Sandler Maintains Overweight
2022-05-11 Stephens & Co. Maintains Overweight
2021-11-05 HC Wainwright & Co. Maintains Buy
2021-10-15 HC Wainwright & Co. Maintains Buy
2021-08-06 HC Wainwright & Co. Maintains Buy
2021-06-18 HC Wainwright & Co. Maintains Buy